2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2003-11-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2003.08.055PMID 14592493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Corticotropin-releasing hormone in depression and post-traumatic stress disorder.

  2001cited by this paper
• Role of CRF(1) and CRF(2) receptors in fear and anxiety.

  2001cited by this paper
• The CRF Receptor Structure, Function and Potential for Therapeutic Intervention.

  2001cited by this paper
• Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents.

  2000cited by this paper
• Expression and characterisation of human and rat CRF2alpha receptors.

  1999cited by this paper
• The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety.

  1999cited by this paper
• Expression and characterisation of human and rat CRF2α receptors

  1999cited by this paper
• Corticotropin‐Releasing Hormone and Inflammation

  1998cited by this paper
• Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats

  1997cited by this paper
• CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

  1996cited by this paper
• Functional corticotropin-releasing factor receptors in human neuroblastoma cells.

  1996cited by this paper
• Design and synthesis of a series of non-peptide high-affinity human corticotropin-releasing factor1 receptor antagonists.

  1996cited by this paper
• CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.

  1992cited by this paper
• Pathways to the Secretion of Adrenocorticotropin: A View from the Portal *

  1991cited by this paper
• Physiology and pharmacology of corticotropin-releasing factor.

  1991cited by this paper
• An Alternative Procedure for the Aluminum-Mediated Conversion of Esters to Amides

  1983cited by this paper
• The reaction of ketones with halogens and thiourea.

  1945cited by this paper

• Dakin-West Reaction of N-Thioacylprolines Using Trifluoroacetic Anhydride: Novel Access to 5-Trifluoromethylthiazoles.

  2014cites this paper
• Fluorinated Oxazoles, Thiazoles and Selenazoles

  2014cites this paper
• Fundamental chemistry of iodine. The reaction of di-iodine towards thiourea and its methyl-derivative: formation of aminothiazoles and aminothiadiazoles through dicationic disulfides.

  2014cites this paper
• Discovery of 6-chloro-2-trifluoromethyl-7-aryl-7H-imidazo[1,2-a]imidazol-3-ylmethylamines, a novel class of corticotropin-releasing factor receptor type 1 (CRF1R) antagonists.

  2010cites this paper
• Chapter 5.5 - Five-Membered Ring Systems: With N and S (Se) Atoms

  2009cites this paper
• Halogenation of fluorinated cyclic 1,3-dicarbonyl compounds: new aspects of synthetic application

  2009cites this paper
• Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments.

  2008cites this paper
• Chapter 1 Recent Advances in Corticotropin-Releasing Factor Receptor Antagonists

  2008cites this paper
• An orally active corticotropin releasing factor 1 receptor antagonist from 8-aryl-1,3a,7,8-tetraaza-cyclopenta[a]indenes.

  2007cites this paper
• Corticotropin-releasing factor receptor antagonists

  2006cites this paper
• Recent advances in small molecule antagonists of the corticotropin-releasing factor type-1 receptor-focus on pharmacology and pharmacokinetics.

  2006cites this paper
• The psychobiology of anxiety

  2005cites this paper
• Optimization of CRF1R binding affinity of 2-(2,4,6-trichlorophenyl)-4-trifluoromethyl-5-aminomethylthiazoles through rapid and selective parallel synthesis.

  2005cites this paper
• THE SYNTHESIS OF FLUORINATED HETEROAROMATIC COMPOUNDS. PART 1. FIVE-MEMBERED RINGS WITH MORE THAN TWO HETEROATOMS. A REVIEW

  2005cites this paper
• CRF antagonists as novel treatment strategies for stress-related disorders

  2005cites this paper
• Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.

  2005cites this paper
• Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists.

  2005cites this paper
• 2‐Arylaminothiazoles as High‐Affinity Corticotropin‐Releasing Factor 1 Receptor (CRF1R) Antagonists: Synthesis, Binding Studies and Behavioral Efficacy.

  2004cites this paper
• The therapeutic potential of CRF1 antagonists for anxiety

  2004cites this paper
• Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases.

  2004cites this paper